首页> 美国卫生研究院文献>Scientific Reports >Legionella SBT applied directly to respiratory samples as a rapid molecular epidemiological tool
【2h】

Legionella SBT applied directly to respiratory samples as a rapid molecular epidemiological tool

机译:军团菌SBT作为快速的分子流行病学工具直接应用于呼吸道样本

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Legionnaires’ disease (LD) is an atypical pneumonia caused by the inhalation of Legionella. The methods used for the diagnosis of LD are direct culture of respiratory samples and urinary antigen detection. However, the sensitivity of culture is low, and the urinary antigen test is specific only for L. pneumophila sg1. Moreover, as no isolates are obtained, epidemiological studies cannot be performed. The implementation of Nested-sequence-based typing (Nested-SBT) makes it possible to carry out epidemiological studies while also confirming LD, especially in cases caused by non-sg 1. Sixty-two respiratory samples from patients with Legionella clinically confirmed by positive urinary antigen tests were cultured and tested by Nested-SBT, following the European Study Group for Legionella Infections (ESGLI) protocol. Only 2/62 (3.2%) respiratory samples were culture-positive. Amplification and sequencing of Nested-SBT genes were successfully performed in 57/62 samples (91.9%). The seven target genes were characterised in 39/57 (68.4%) respiratory samples, and the complete sequence type (ST) was obtained. The mip gene was the most frequently amplified and sequenced. Nested-SBT is a useful method for epidemiological studies in culture-negative samples, achieving a 28.7-fold improvement over the results of culture studies and reducing the time needed to obtain molecular epidemiological results.
机译:军团菌病(LD)是由吸入军团菌引起的非典型肺炎。诊断LD的方法是直接培养呼吸道样本和检测尿液抗原。但是,培养的敏感性低,尿抗原检测仅对嗜肺乳杆菌sg1具有特异性。此外,由于没有分离株,因此无法进行流行病学研究。基于嵌套序列分型(Nested-SBT)的实施使得可以进行流行病学研究,同时也可以确定LD,特别是在非sg引起的病例中。1.临床上通过阳性确诊的军团菌患者有62份呼吸道样本按照欧洲军团菌感染研究小组(ESGLI)协议,通过Nested-SBT培养和测试尿液抗原测试。只有2/62(3.2%)呼吸道样本培养阳性。 Nested-SBT基因的扩增和测序在57/62个样品中成功进行(91.9%)。在39/57(68.4%)呼吸道样本中鉴定了这七个靶基因,并获得了完整的序列类型(ST)。 mip基因是最常扩增和测序的。 Nested-SBT是在培养阴性样本中进行流行病学研究的有用方法,比培养研究结果提高了28.7倍,并减少了获得分子流行病学结果所需的时间。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号